472 Telazorlimab in atopic dermatitis: Phase 2b study shows improvement at 16 weeks

Autor:	M. Mbow, L. Sher, A. Acocella, N. Mozaffarian, Girish Gudi, K. Changela, B. Rewerska, Yacine Salhi
Rok vydání:	2021
Předmět:	medicine.medical_specialty business.industry Phase (matter) Medicine Cell Biology Dermatology Atopic dermatitis business medicine.disease Molecular Biology Biochemistry
Zdroj:	Journal of Investigative Dermatology. 141:S82
ISSN:	0022-202X
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a363626ba42833d5f35459d70ccdcaca https://doi.org/10.1016/j.jid.2021.02.496 Zobrazit plný text záznamu